• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
0.00% 0.5¢

ALTERITY THERAPEUTICS LIMITED - Corporate Spotlight

Market Cap $26.22M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.6¢ 0.5¢ $3.342K 666.1K

Buyers (Bids)

No. Vol. Price($)
37 32719984 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 15288198 22
View Market Depth
Last trade - 14.04pm 29/05/2024 (20 minute delay) ?
Last
0.6¢ 		  Change
0.000 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 140816
Last updated 11.48am 29/05/2024 ?
ATH (ASX) Chart

Top Stories

ASX200 sells off as CPI inflation hotter than expected at 3.6%. Are we over-reacting?

Australia's CPI inflation indicator increased in April by 3.6% on a YoY basis, causing an instant sell off on the ASX200.
Oar Minerals see shares rise 33% on news of massive Brazilian land increase Oar Resources Ltd has increased its landholding in Brazil by 283%, picking up two additional uranium projects.
De Grey raises $600M to progress work at WA's Hemi Gold Project De Grey Mining Ltd has raised a total of $600 million to fund work at its Hemi Gold Project in Western Australia.
Chris Judd and Hashan De Silva on CT scans done standing up AFL great, turned Cerutty Macro Fund portfolio manager, Chris Judd is with HP Rx founder and managing partner Hashan De Silva for today's Talk Ya Book discussing CurveBeam AI (ASX:CVB) for today's Talk Ya Book.
Daily ASX Market Close: BHP Anglo American proposal update - May 29, 2024 The ASX200 didn’t seem to be able to recover from the CPI inflation data April read – showing a rise to 3.6 per cent – which was hotter than many had forecast. The index lost more than 1.15 per cent – all sectors were down with Consumer Staples, Industrials and Financials suffering the most.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.